Eli Lilly attacks weight-loss drug knockoffs as competition intensifies
Eli Lilly unleashed a flurry of lawsuits against wellness centers, medical spas and others the pharmaceutical company accused of illegally…
Category: GLP-1
Zealand Deepens Weight-Loss Portfolio With Strong Phase Ib Data for GLP-1 Alternative
Zealand Pharma on Thursday posted interim Phase Ib data for its investigational amylin analog petrelintide, touting strong weight reduction and a favorable tolerability…
GLP-1 Receptor Agonists Improved Psoriasis Despite Diabetes Mellitus
In this systematic review and meta-analysis, the clinical efficacy of glucagon-like peptide 1 receptor agonists was evaluated. Credit: Pixabay Treating psoriasis with…
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing…
Endocrine Today: SURMOUNT-OSA Study Shows Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity
Key takeaways: ORLANDO — The GIP/GLP-1 dual agonist tirzepatide reduced symptoms of obstructive sleep apnea and improved multiple cardiometabolic markers…
Ozempic’s Hidden Challenges: A Personal Journey of Weight Loss and Self-Discovery
Author Johann Hari shares his experience with Ozempic, revealing both the benefits and unexpected psychological toll of the popular weight-loss…
Title: The Paradox of GLP-1 Receptor Agonists: Increased Osteoarthritis Progression in Diabetic Patients
A recent study published in The Journal of Arthroplasty has revealed unexpected findings regarding the effects of glucagon-like peptide-1 receptor…
GLP-1 Drugs Like Ozempic Set to Shake Up the Snack Food Industry
The snack food industry is bracing for a seismic shift as the popularity of GLP-1 medications, such as Ozempic and…
GLP-1 Drugs and Weight Loss Surgeries Demonstrate Comparable Reductions in Obesity-Related Cancers
A groundbreaking study has revealed that the use of GLP-1 receptor agonist medications, such as Ozempic and Wegovy, may be…
Diabesitology: A Call for Novel Clinical Trial Designs in the Golden Era of GLP-1 Axis Medications
As we enter what many experts are calling the “golden era” of GLP-1 axis medications, a new field of study—”diabesitology”—is…
